Reuters
Reuters
@Reuters·4.2M subscribers·86.9K videos

Novo Nordisk's run of hiking sales guidance could be ending | REUTERS

Posted

April 24, 2025

Views

1,050

Likes

13

Engagement

1.24%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Since launching its popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several times a year. But recent weak US prescription data is leading some people to question whether this is coming to an end

#business #wegovy #pharmacy #News #Reuters #Newsfeed

Read the story here

👉 Subscribe

Keep up with the latest news from around the world

Follow Reuters on Facebook

Follow Reuters on Twitter

Follow Reuters on Instagram

Guests & Subjects Covered

Novo NordiskNews Reuters Newsfeed ReadSubscribe KeepFollow ReutersFacebook Follow ReutersTwitter Follow Reuters

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Novo Nordisk's run of hiking sales guidance could be ending | REUTERS · Reuters · Sentinel